Doximity (NYSE:DOCS) Shares Up 4.3% – Here’s What Happened

Doximity, Inc. (NYSE:DOCS) shares shot up 4.3% during trading on Thursday. The company traded as high as $29.00 and last traded at $28.8890. Approximately 674,629 shares traded hands during mid-day trading, a decline of 83% from the average daily volume of 3,981,646 shares. The stock had previously closed at $27.69.

Key Headlines Impacting Doximity

Here are the key news stories impacting Doximity this week:

• Positive Sentiment: RBC Capital reaffirmed its Buy rating on Doximity, providing a bullish counterpoint to the litigation headlines and suggesting the firm sees potential in the company’s long-term outlook. RBC Capital Reaffirms Their Buy Rating on Doximity
• Neutral Sentiment: Multiple law firms publicized the same pending securities class action and reminded investors that November 16, 2026 is the deadline to seek appointment as lead plaintiff. The notices primarily seek participation from shareholders who bought Doximity securities between August 8, 2024, and May 13, 2026, rather than announcing separate new lawsuits. Bronstein Gewirtz Grossman Doximity Class Action Notice
• Negative Sentiment: The lawsuit alleges Doximity misled investors about business momentum. Claims highlighted in the notices include alleged loss of market share to competitors, slowing revenue growth, reduced fiscal 2026 guidance, and a subsequent failure to meet that lowered outlook. The allegations also question disclosures about Newsfeed engagement, banner advertising, e-newsletters, and pharmaceutical customers’ changing advertising spending. These claims have not been proven. SueWallSt Doximity Class Action Notice
• Negative Sentiment: An insider sale was also reported: Kira Scherer Wampler sold 2,000 Doximity shares. The transaction is small relative to the company’s market value, but insider selling can modestly weigh on sentiment. Doximity Insider Share Sale

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on DOCS. Bank of America reiterated an “underperform” rating and set a $20.00 price objective (down from $38.00) on shares of Doximity in a research note on Monday, June 29th. Zacks Research raised Doximity from a “strong sell” rating to a “hold” rating in a research note on Monday, July 13th. Freedom Capital downgraded Doximity from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 8th. Wolfe Research raised Doximity to an “outperform” rating in a research report on Thursday, August 13th. Finally, Truist Financial upped their price target on shares of Doximity from $19.00 to $24.00 and gave the stock a “hold” rating in a research note on Thursday, August 13th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, fourteen have issued a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $31.95.

Doximity Stock Up 4.3%

The stock has a market capitalization of $5.15 billion, a P/E ratio of 34.00, a P/E/G ratio of 21.74 and a beta of 1.22. The business has a fifty day moving average price of $25.60 and a 200-day moving average price of $23.32.

Doximity (NYSE:DOCS) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.29 EPS for the quarter, topping the consensus estimate of $0.16 by $0.13. Doximity had a return on equity of 18.06% and a net margin of 25.48%.The company had revenue of $156.62 million during the quarter. During the same quarter in the previous year, the business posted $0.36 earnings per share. Doximity’s quarterly revenue was up 7.3% compared to the same quarter last year. On average, equities analysts expect that Doximity, Inc. will post 0.74 earnings per share for the current fiscal year.

Insider Activity at Doximity

In related news, Director Kira Wampler sold 2,000 shares of the firm’s stock in a transaction that occurred on Thursday, October 1st. The shares were sold at an average price of $28.91, for a total value of $57,820.00. Following the sale, the director owned 27,923 shares in the company, valued at approximately $807,253.93. This trade represents a 6.68% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Siddharth Sitaram sold 2,077 shares of the firm’s stock in a transaction that occurred on Tuesday, September 15th. The stock was sold at an average price of $26.02, for a total transaction of $54,043.54. Following the completion of the sale, the chief accounting officer owned 96,045 shares in the company, valued at $2,499,090.90. This represents a 2.12% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders have sold 16,637 shares of company stock valued at $533,688. Insiders own 31.80% of the company’s stock.

Institutional Investors Weigh In On Doximity

A number of hedge funds have recently added to or reduced their stakes in DOCS. Versant Capital Management Inc grew its holdings in shares of Doximity by 1,176.9% in the third quarter. Versant Capital Management Inc now owns 1,826 shares of the company’s stock worth $52,000 after acquiring an additional 1,683 shares during the period. Parallel Advisors LLC lifted its holdings in Doximity by 111.0% in the first quarter. Parallel Advisors LLC now owns 2,560 shares of the company’s stock valued at $60,000 after acquiring an additional 1,347 shares during the period. EverSource Wealth Advisors LLC lifted its holdings in Doximity by 937.7% in the first quarter. EverSource Wealth Advisors LLC now owns 2,833 shares of the company’s stock valued at $66,000 after acquiring an additional 2,560 shares during the period. Continuum Advisory LLC purchased a new position in Doximity in the second quarter worth about $67,000. Finally, Leonteq Securities AG boosted its position in Doximity by 65.6% in the first quarter. Leonteq Securities AG now owns 2,912 shares of the company’s stock worth $68,000 after purchasing an additional 1,154 shares during the last quarter. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

About Doximity

Doximity, Inc operates a digital platform designed for U.S. medical professionals. Its network enables physicians, nurse practitioners, physician assistants and other healthcare providers to connect with colleagues, exchange clinical information and access professional resources.

The company offers tools for telehealth and care coordination, including video and phone-based communication services, as well as digital faxing and secure messaging capabilities. Doximity also provides medical news and research content tailored to healthcare professionals.

Doximity generates additional business through recruiting and marketing solutions that help healthcare organizations reach clinicians and promote employment opportunities, services and products.